HANNAH ALISON L. has filed 15 insider transactions across 2 companies since May 2023.
Most recent transaction: a option exercise of 12254 shares of NEOGENOMICS INC ($NEO) on June 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 1, 2025 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | M | Restricted Stock Unit | 12254 | $0.00 | 0.0000 | 128,461,383 | 100.00% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | A | Common Stock | 12254 | $0.00 | 131,023.0000 | 128,461,383 | 10.32% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | A | Restricted Stock Unit | 23077 | $0.00 | 23,077.0000 | 128,461,383 | 9999.99% | 0.02% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | A | Stock Option (Right to Buy) | 16107 | $0.00 | 33,132.0000 | 128,461,383 | 94.61% | 0.01% |
| June 1, 2025 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | M | Common Stock | 12254 | $0.00 | 131,023.0000 | 128,461,383 | 10.32% | 0.01% |
| May 23, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | HANNAH ALISON L. | Not found | A | Common Stock | 2500 | $0.00 | 10,625.0000 | 18,169,000 | 30.77% | 0.01% |
| May 23, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | HANNAH ALISON L. | Not found | A | Stock Option (Right to Buy) | 3000 | $0.00 | 3,000.0000 | 18,169,000 | 9999.99% | 0.02% |
| Aug. 10, 2024 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | M | Common Stock | 11336 | $0.00 | 118,769.0000 | 0 | 10.55% | 0.00% |
| Aug. 10, 2024 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | M | Restricted Stock Unit | 11336 | $0.00 | 12,254.0000 | 0 | 48.05% | 0.00% |
| June 1, 2024 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | A | Stock Option (Right to Buy) | 8672 | $0.00 | 17,025.0000 | 0 | 103.82% | 0.00% |
| June 1, 2024 | NEOGENOMICS INC | $NEO | HANNAH ALISON L. | Director | A | Restricted Stock Unit | 12254 | $0.00 | 23,590.0000 | 0 | 108.10% | 0.00% |
| May 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | HANNAH ALISON L. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 17,520,000 | 9999.99% | 0.17% |
| May 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | HANNAH ALISON L. | Not found | A | Common Stock | 25000 | $0.00 | 81,250.0000 | 17,520,000 | 44.44% | 0.14% |
| May 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | HANNAH ALISON L. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 173,568,000 | 9999.99% | 0.02% |
| May 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | HANNAH ALISON L. | Not found | A | Common Stock | 25000 | $0.00 | 56,250.0000 | 173,568,000 | 80.00% | 0.01% |